OPPOSITION DIVISION
OPPOSITION Nо B 3 107 171
A-Mansia Biotech Société Anonyme, Rue Granbonpré 11, 1435 Mont-Saint-Guibert, Belgium (opponent), represented by De Clercq & Partners, Edgard Gevaertdreef 10 a, 9830 Sint-Martens-Latem, Belgium (professional representative)
a g a i n s t
Phytopharm Klęka S. A., Klęka 1, 63-040 Nowe Miasto Nad Wartą, Poland (applicant), represented by Biuro Ochrony Własności Intelektualnej Patent-Service Paweł Górnicki, Ul. Rybojadzka 16, 60-443 Poznań, Poland (professional representative).
On 04/03/2021, the Opposition Division takes the following
DECISION:
1. |
Opposition No B 3 107 171 is rejected in its entirety. |
2. |
The opponent bears the costs, fixed at EUR 300. |
The opponent filed an opposition against all the goods of European Union trade mark application No 18 107 717 ‘mucobione’ (word mark), namely against all the goods in Class 5. The opposition is based on European Union trade mark application No 18 088 223 ‘MUCIBIOME’ (word mark). The opponent invoked Article 8(1)(b) EUTMR.
CEASING OF EXISTENCE OF THE EARLIER RIGHT
According to Article 46(1)(a) EUTMR, within a period of three months following the publication of an EUTM application, notice of opposition to registration of the trade mark may be given on the grounds that it may not be registered under Article 8:
(a) by the proprietors of earlier trade marks referred to in Article 8(2) as well as licensees authorised by the proprietors of those trade marks, in respect of Article 8(1) and 8(5);
[…].
Furthermore, according to Article 8(2) EUTMR, ‘earlier trade mark’ means:
(i) trade marks with a date of application for registration which is earlier than the date of application of the contested mark, taking account, where appropriate, of the priorities claimed in respect of the marks referred to in Article 8(2)(a) EUTMR;
(ii) applications for a trade mark referred to in Article 8(2)(a) EUTMR, subject to their registration;
(iii) trade marks which are well known in a Member State.
Therefore, the legal basis of the opposition requires the existence and validity of an earlier right within the meaning of Article 8(2) EUTMR.
In this respect, if, in the course of the proceedings, the earlier right ceases to exist (e.g. because it has been declared invalid or it has not been renewed), the final decision cannot be based on it. The opposition may be upheld only with respect to an earlier right that is valid at the moment when the decision is taken. The reason why the earlier right ceases to have effect does not matter. Since the EUTM application and the earlier right that has ceased to have effect cannot coexist any more, the opposition cannot be upheld to this extent. Such a decision would be unlawful (13/09/2006, T‑191/04, Metro, EU:T:2006:254, § 33-36).
On 23/12/2019, the opponent filed a notice of opposition claiming as the basis of the opposition European Union trade mark application No 18 088 223 for the word mark ‘MUCIBIOME’ which was filed on 28/06/2019.
However, opponent withdraw this trade mark application on 20/10/2020.
As it is apparent from the facts stated above, the earlier mark ceased to exist and thus cannot constitute a valid trade mark on which the opposition can be based within the meaning of Article 46(1)(a) EUTMR and Article 8(2) EUTMR.
For the sake of completeness the Opposition Division notes that although in the withdrawal request of its earlier right filed on 20/10/2020, the opponent commented that as the European Union trade mark application No 18 088 223 for the word mark ‘MUCIBIOME’ is also the bases for current opposition, these proceedings will be terminated as a consequence of the withdrawal, this comment cannot be considered as a unambiguous withdrawal of current opposition.
In view of this, on 20/11/2020 the opponent was requested to inform the Office by 25/01/2021 whether it maintained the opposition. The opponent did not reply to this notification.
The opposition must therefore be rejected as unfounded.
According to Article 109(1) EUTMR, the losing party in opposition proceedings must bear the fees and costs incurred by the other party.
Since the opponent is the losing party, it must bear the costs incurred by the applicant in the course of these proceedings.
According to Article 109(7) EUTMR and Article 18(1)(c)(i) EUTMIR, the costs to be paid to the applicant are the costs of representation, which are to be fixed on the basis of the maximum rate set therein.
The Opposition Division
Monika CISZEWSKA |
Reet ESCRIBANO |
According to Article 67 EUTMR, any party adversely affected by this decision has a right to appeal against this decision. According to Article 68 EUTMR, notice of appeal must be filed in writing at the Office within two months of the date of notification of this decision. It must be filed in the language of the proceedings in which the decision subject to appeal was taken. Furthermore, a written statement of the grounds for appeal must be filed within four months of the same date. The notice of appeal will be deemed to have been filed only when the appeal fee of EUR 720 has been paid.